Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Censoring Survival Data01:09

Censoring Survival Data

243
Survival analysis is a statistical method used to analyze time-to-event data, often employed in fields such as medicine, engineering, and social sciences. One of the key challenges in survival analysis is dealing with incomplete data, a phenomenon known as "censoring." Censoring occurs when the event of interest (such as death, relapse, or system failure) has not occurred for some individuals by the end of the study period or is otherwise unobservable, and it might have many different...
243
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

199
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
199
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

292
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
292
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

404
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
404
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

274
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
274
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

318
Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
318

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Win Ratio as an Effect Size Measure Under Non-Proportional Hazards: A Comparison With Difference in Restricted Mean Survival.

Statistics in medicine·2026
Same author

Comparing adaptive treatment strategies in two-stage randomized trials with grouped survival data.

Lifetime data analysis·2026
Same author

Temporary Knockdown of p53 During Focal Limb Irradiation Increases the Development of Sarcomas.

Cancer research communications·2023
Same author

Efficient estimation of grouped survival models.

BMC bioinformatics·2019
Same author

Sample size calculation for studies with grouped survival data.

Statistics in medicine·2018

相关实验视频

Updated: Sep 16, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K

在顺序的多重分配随机试验中分析间隔审查的生存数据.

Zhiguo Li1

  • 1Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA. zhiguo.li@duke.edu.

Lifetime data analysis
|July 11, 2025
PubMed
概括

这项研究引入了新的统计方法,用于分析间隔审查的时间到事件数据,在顺序多重分配随机试验 (SMART) 内的适应性治疗策略中. 这些方法可以对复杂的临床试验设计进行可靠的推断,而此前缺乏适当的分析技术.

科学领域:

  • 生物统计学 生物统计学
  • 临床试验方法论 临床试验方法论
  • 生存分析的分析.

背景情况:

  • 顺序多重分配随机试验 (SMART) 的现有方法主要针对连续或右审查的数据.
  • 在心理学和其他领域中常见的间隔审查的时间到事件结果,在SMART设计中缺乏成熟的分析技术.

研究的目的:

  • 在SMART研究中开发和验证用于分析间隔审查的时间到事件结果的统计方法.
  • 为了提供一个框架,使得推断适应性治疗策略,当事件时间只有在间隔内是已知的.

主要方法:

  • 提出了一个基于spline的加权选最大概率的推理方法.
  • 使用沃尔德测试来评估群体差异.
  • 导出危险比率估计器的非对称性质,并解决差异估计.

主要成果:

  • 开发的方法为SMART.中处理间隔审查数据提供了一种可行的方法.
  • 模拟研究评估了拟议方法的有限样本性能.
  • 这些方法应用于测序治疗替代方法缓解抑郁症 (STAR*D) 试验的数据.

结论:

  • 这项研究填补了对使用间隔审查结果的SMART研究分析的关键缺口.
关键词:
适应性治疗策略是一种适应性治疗策略.间隔审查的数据数据间隔.相称危险模型的比例危险模型.顺序的多重分配随机试验随机试验.基于线的加权子最大概率.

更多相关视频

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K

相关实验视频

Last Updated: Sep 16, 2025

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.3K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.6K
  • 提出的方法为复杂的临床试验数据提供了统计学上合理的方法.
  • 这些发现对设计和分析未来适应性治疗试验有影响.